Download PDF
Semin Liver Dis 2008; 28(4): 339-350
DOI: 10.1055/s-0028-1091978
© Thieme Medical Publishers

The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective

Mariana Lazo1 , 2 , Jeanne M. Clark1 , 2 , 3
  • 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 2Welch Center for Prevention, Epidemiology, and Clinical Research, Baltimore, Maryland
  • 3Department of Medicine, Johns Hopkins University, Baltimore, Maryland
Further Information

Publication History

Publication Date:
27 October 2008 (online)

    Permissions and Reprints

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver disease in the United States and worldwide. With obesity being an important risk factor universally, NAFLD is now receiving greater attention and is regarded as a public health issue. In addition, as a result of an aging population and the improving control of other major causes of chronic liver disease, such as hepatitis C and hepatitis B, the burden of NAFLD is expected to increase in years to come. Prevalence estimates of this disease vary widely across populations because of differences in methods for diagnosis and/or definition. New strategies for the prevention, diagnosis, and management will be required to alter the course of this disease.

KEYWORDS

Nonalcoholic fatty liver disease - NAFLD - epidemiology - risk factors

REFERENCES

  • 1 Brunt E M. Nonalcoholic steatohepatitis.  Semin Liver Dis. 2004;  24(1) 3-20
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Bugianesi E, Leone N, Vanni E et al.. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.  Gastroenterology. 2002;  123(1) 134-140
    CrossrefPubMedGoogle Scholar
  • 3 Clark J M, Diehl A M. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis.  JAMA. 2003;  289(22) 3000-3004
    CrossrefPubMedGoogle Scholar
  • 4 Abdelmalek M F, Diehl A M. Nonalcoholic fatty liver disease as a complication of insulin resistance.  Med Clin North Am. 2007;  91(6) 1125-1149 , ix
    CrossrefPubMedGoogle Scholar
  • 5 Brunt E M. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis.  Semin Diagn Pathol. 2005;  22(4) 330-338
    CrossrefPubMedGoogle Scholar
  • 6 Ogden C L, Carroll M D, Curtin L R, McDowell M A, Tabak C J, Flegal K M. Prevalence of overweight and obesity in the United States, 1999–2004.  JAMA. 2006;  295(13) 1549-1555
    CrossrefPubMedGoogle Scholar
  • 7 Clark J M. The epidemiology of nonalcoholic fatty liver disease in adults.  J Clin Gastroenterol. 2006;  40(suppl 1) S5-S10
    PubMedGoogle Scholar
  • 8 Falck-Ytter Y, Younossi Z M, Marchesini G, McCullough A J. Clinical features and natural history of nonalcoholic steatosis syndromes.  Semin Liver Dis. 2001;  21(1) 17-26
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Neuschwander-Tetri B A, Caldwell S H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.  Hepatology. 2003;  37(5) 1202-1219
    CrossrefPubMedGoogle Scholar
  • 10 Yeh M M, Brunt E M. Pathology of nonalcoholic fatty liver disease.  Am J Clin Pathol. 2007;  128(5) 837-847
    CrossrefPubMedGoogle Scholar
  • 11 Ratziu V, Charlotte F, Heurtier A et al.. Sampling variability of liver biopsy in nonalcoholic fatty liver disease.  Gastroenterology. 2005;  128(7) 1898-1906
    CrossrefPubMedGoogle Scholar
  • 12 Mofrad P, Contos M J, Haque M et al.. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.  Hepatology. 2003;  37(6) 1286-1292
    CrossrefPubMedGoogle Scholar
  • 13 Yano E, Tagawa K, Yamaoka K, Mori M. Test validity of periodic liver function tests in a population of Japanese male bank employees.  J Clin Epidemiol. 2001;  54(9) 945-951
    CrossrefPubMedGoogle Scholar
  • 14 Lazo M, Selvin E, Clark J M. Brief Communication: Clinical implications of short-term variability in liver function test results.  Ann Intern Med. 2008;  148 348-352
    CrossrefPubMedGoogle Scholar
  • 15 Clark J M, Brancati F L, Diehl A M. Nonalcoholic fatty liver disease.  Gastroenterology. 2002;  122(6) 1649-1657
    CrossrefPubMedGoogle Scholar
  • 16 Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver.  AJR Am J Roentgenol. 2007;  189(6) W320-W323
    CrossrefPubMedGoogle Scholar
  • 17 Szczepaniak L S, Nurenberg P, Leonard D et al.. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.  Am J Physiol Endocrinol Metab. 2005;  288(2) E462-E468
    CrossrefPubMedGoogle Scholar
  • 18 Clouston A D, Jonsson J R, Powell E E. Steatosis as a cofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis, and others.  Clin Liver Dis. 2007;  11(1) 173-189 , x
    CrossrefPubMedGoogle Scholar
  • 19 Adinolfi L E, Gambardella M, Andreana A, Tripodi M F, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.  Hepatology. 2001;  33(6) 1358-1364
    CrossrefPubMedGoogle Scholar
  • 20 Friedenberg F, Pungpapong S, Zaeri N, Braitman L E. The impact of diabetes and obesity on liver histology in patients with hepatitis C.  Diabetes Obes Metab. 2003;  5(3) 150-155
    CrossrefPubMedGoogle Scholar
  • 21 Lonardo A, Adinolfi L E, Loria P, Carulli N, Ruggiero G, Day C P. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease.  Gastroenterology. 2004;  126(2) 586-597
    CrossrefPubMedGoogle Scholar
  • 22 Patton H M, Patel K, Behling C et al.. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.  J Hepatol. 2004;  40(3) 484-490
    CrossrefPubMedGoogle Scholar
  • 23 Pekow J R, Bhan A K, Zheng H, Chung R T. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.  Cancer. 2007;  109(12) 2490-2496
    CrossrefPubMedGoogle Scholar
  • 24 Ramesh S, Sanyal A J. Hepatitis C and nonalcoholic fatty liver disease.  Semin Liver Dis. 2004;  24(4) 399-413
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Leandro G, Mangia A, Hui J et al.. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.  Gastroenterology. 2006;  130(6) 1636-1642
    CrossrefPubMedGoogle Scholar
  • 26 Thomopoulos K C, Arvaniti V, Tsamantas A C et al.. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis.  Eur J Gastroenterol Hepatol. 2006;  18(3) 233-237
    CrossrefPubMedGoogle Scholar
  • 27 Hadigan C, Liebau J, Andersen R, Holalkere N S, Sahani D V. Magnetic resonance spectroscopy of hepatic lipid content and associated risk factors in HIV infection.  J Acquir Immune Defic Syndr. 2007;  46(3) 312-317
    CrossrefPubMedGoogle Scholar
  • 28 Clouston A D, Powell E E. Interaction of non-alcoholic fatty liver disease with other liver diseases.  Best Pract Res Clin Gastroenterol. 2002;  16(5) 767-781
    CrossrefPubMedGoogle Scholar
  • 29 Zhou Y J, Li Y Y, Nie Y Q et al.. Prevalence of fatty liver disease and its risk factors in the population of South China.  World J Gastroenterol. 2007;  13(47) 6419-6424
    CrossrefPubMedGoogle Scholar
  • 30 Fan J G, Li F, Cai X B, Peng Y D, Ao Q H, Gao Y. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers.  J Gastroenterol Hepatol. 2007;  22(5) 663-668
    PubMedGoogle Scholar
  • 31 Lin T J, Lin C L, Wang C S, Liu S O, Liao L Y. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.  World J Gastroenterol. 2005;  11(25) 3905-3908
    CrossrefPubMedGoogle Scholar
  • 32 Fan J G, Zhu J, Li X J et al.. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China.  J Hepatol. 2005;  43(3) 508-514
    CrossrefPubMedGoogle Scholar
  • 33 Shen L, Fan J G, Shao Y et al.. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey.  World J Gastroenterol. 2003;  9(5) 1106-1110
    PubMedGoogle Scholar
  • 34 Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.  Liver Int. 2006;  26(7) 856-863
    CrossrefPubMedGoogle Scholar
  • 35 Kagansky N, Levy S, Keter D et al.. Non-alcoholic fatty liver disease: a common and benign finding in octogenarian patients.  Liver Int. 2004;  24(6) 588-594
    CrossrefPubMedGoogle Scholar
  • 36 Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.  Hepatology. 2005;  42(1) 44-52
    CrossrefPubMedGoogle Scholar
  • 37 Hamaguchi M, Kojima T, Takeda N et al.. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.  Ann Intern Med. 2005;  143(10) 722-728
    CrossrefPubMedGoogle Scholar
  • 38 Jimba S, Nakagami T, Takahashi M et al.. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.  Diabet Med. 2005;  22(9) 1141-1145
    CrossrefPubMedGoogle Scholar
  • 39 Omagari K, Kadokawa Y, Masuda J et al.. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.  J Gastroenterol Hepatol. 2002;  17(10) 1098-1105
    CrossrefPubMedGoogle Scholar
  • 40 Kim H J, Kim H J, Lee K E et al.. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.  Arch Intern Med. 2004;  164(19) 2169-2175
    CrossrefPubMedGoogle Scholar
  • 41 Lizardi-Cervera J, Laparra D I, Chavez-Tapia N C, Ostos M E, Esquivel M U. Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects.  Rev Gastroenterol Mex. 2006;  71(4) 453-459
    PubMedGoogle Scholar
  • 42 Chen C H, Huang M H, Yang J C et al.. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.  J Clin Gastroenterol. 2006;  40(8) 745-752
    CrossrefPubMedGoogle Scholar
  • 43 Park S H, Jeon W K, Kim S H et al.. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults.  J Gastroenterol Hepatol. 2006;  21(1) 138-143
    CrossrefPubMedGoogle Scholar
  • 44 Lin Y C, Lo H M, Chen J D. Sonographic fatty liver, overweight and ischemic heart disease.  World J Gastroenterol. 2005;  11(31) 4838-4842
    CrossrefPubMedGoogle Scholar
  • 45 Church T S, Kuk J L, Ross R, Priest E L, Biltoft E, Blair S N. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.  Gastroenterology. 2006;  130(7) 2023-2030
    CrossrefPubMedGoogle Scholar
  • 46 Browning J D, Szczepaniak L S, Dobbins R et al.. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.  Hepatology. 2004;  40(6) 1387-1395
    CrossrefPubMedGoogle Scholar
  • 47 Pendino G M, Mariano A, Surace P et al.. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town.  Hepatology. 2005;  41(5) 1151-1159
    CrossrefPubMedGoogle Scholar
  • 48 Suzuki A, Angulo P, Lymp J et al.. Chronological development of elevated aminotransferases in a nonalcoholic population.  Hepatology. 2005;  41(1) 64-71
    CrossrefPubMedGoogle Scholar
  • 49 Clark J M, Brancati F L, Diehl A M. The prevalence and etiology of elevated aminotransferase levels in the United States.  Am J Gastroenterol. 2003;  98(5) 960-967
    CrossrefPubMedGoogle Scholar
  • 50 Ruhl C E, Everhart J E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.  Gastroenterology. 2003;  124(1) 71-79
    CrossrefPubMedGoogle Scholar
  • 51 Amarapurkar A, Ghansar T. Fatty liver: experience from western India.  Ann Hepatol. 2007;  6(1) 37-40
    PubMedGoogle Scholar
  • 52 Yamamoto K, Takada Y, Fujimoto Y et al.. Nonalcoholic steatohepatitis in donors for living donor liver transplantation.  Transplantation. 2007;  83(3) 257-262
    CrossrefPubMedGoogle Scholar
  • 53 Brunt E M, Janney C G, Di Bisceglie A M et al.. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.  Am J Gastroenterol. 1999;  94 2467-2474
    CrossrefPubMedGoogle Scholar
  • 54 Halon A, Patrzalek D, Rabczynski J. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?.  Transplant Proc. 2006;  38(1) 193-195
    CrossrefPubMedGoogle Scholar
  • 55 Tran T T, Changsri C, Shackleton C R et al.. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.  J Gastroenterol Hepatol. 2006;  21(2) 381-383
    CrossrefPubMedGoogle Scholar
  • 56 Omagari K, Kadokawa Y, Masuda J et al.. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics.  J Gastroenterol Hepatol. 2002;  17(10) 1098-1105
    CrossrefPubMedGoogle Scholar
  • 57 Bedogni G, Miglioli L, Masutti F et al.. Incidence and natural course of fatty liver in the general population: the Dionysos study.  Hepatology. 2007;  46(5) 1387-1391
    CrossrefPubMedGoogle Scholar
  • 58 Ground K E. Liver pathology in aircrew.  Aviat Space Environ Med. 1982;  53(1) 14-18
    PubMedGoogle Scholar
  • 59 Underwood Ground K E. Prevalence of fatty liver in healthy male adults accidentally killed.  Aviat Space Environ Med. 1984;  55(1) 59-61
    PubMedGoogle Scholar
  • 60 Hilden M, Christoffersen P, Juhl E, Dalgaard J B. Liver histology in a “normal” population: examinations of 503 consecutive fatal traffic casualties.  Scand J Gastroenterol. 1977;  12(5) 593-597
    PubMedGoogle Scholar
  • 61 Targher G, Bertolini L, Padovani R et al.. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.  Diabetes Care. 2007;  30(5) 1212-1218
    CrossrefPubMedGoogle Scholar
  • 62 Angelico F, Del B M, Conti R et al.. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.  J Clin Endocrinol Metab. 2005;  90(3) 1578-1582
    CrossrefPubMedGoogle Scholar
  • 63 Gupte P, Amarapurkar D, Agal S et al.. Non-alcoholic steatohepatitis in type 2 diabetes mellitus.  J Gastroenterol Hepatol. 2004;  19(8) 854-858
    CrossrefPubMedGoogle Scholar
  • 64 Roesch-Dietlen F, Dorantes-Cuellar A, Carrillo-Toledo M G et al.. Frequency of NAFLD in a group of patients with metabolic syndrome in Veracruz, Mexico.  Rev Gastroenterol Mex. 2006;  71(4) 446-452
    PubMedGoogle Scholar
  • 65 Gambarin-Gelwan M, Kinkhabwala S V, Schiano T D, Bodian C, Yeh H C, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.  Clin Gastroenterol Hepatol. 2007;  5(4) 496-501
    CrossrefPubMedGoogle Scholar
  • 66 Weston S R, Leyden W, Murphy R et al.. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease.  Hepatology. 2005;  41(2) 372-379
    CrossrefPubMedGoogle Scholar
  • 67 Liangpunsakul S, Chalasani N. Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).  Am J Med Sci. 2005;  329(3) 111-116
    CrossrefPubMedGoogle Scholar
  • 68 Lima M L, Mourao S C, Diniz M T, Leite V H. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass.  Obes Surg. 2005;  15(5) 661-669
    CrossrefPubMedGoogle Scholar
  • 69 de Oliveira C P, de Mello E S, Alves V A, Saviero S M, Strauss E. Changes in histological criteria lead to different prevalences of nonalcoholic steatohepatitis in severe obesity.  Ann Hepatol. 2007;  6(4) 255-261
    PubMedGoogle Scholar
  • 70 Boza C, Riquelme A, Ibanez L et al.. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.  Obes Surg. 2005;  15(8) 1148-1153
    CrossrefPubMedGoogle Scholar
  • 71 Harnois F, Msika S, Sabate J M et al.. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery.  Obes Surg. 2006;  16(2) 183-188
    CrossrefPubMedGoogle Scholar
  • 72 Wolf A M, Busch B, Kuhlmann H W, Beisiegel U. Histological changes in the liver of morbidly obese patients: correlation with metabolic parameters.  Obes Surg. 2005;  15(2) 228-237
    CrossrefPubMedGoogle Scholar
  • 73 Papadia F S, Marinari G M, Camerini G et al.. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies.  Obes Surg. 2004;  14(7) 952-958
    CrossrefPubMedGoogle Scholar
  • 74 Sorrentino P, Tarantino G, Conca P et al.. Silent non-alcoholic fatty liver disease: a clinical-histological study.  J Hepatol. 2004;  41(5) 751-757
    CrossrefPubMedGoogle Scholar
  • 75 Chavarria-Arciniega S, Lopez-Alvarenga J C, Uribe-Uribe N O, Herrera-Hernandez M, Gonzalez-Barranco J. Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity.  Rev Invest Clin. 2005;  57(4) 505-512
    PubMedGoogle Scholar
  • 76 Liew P L, Lee W J, Lee Y C, Wang H H, Wang W, Lin Y C. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.  Obes Surg. 2006;  16(12) 1584-1593
    CrossrefPubMedGoogle Scholar
  • 77 Kleiner D E, Brunt E M, Van Natta M et al.. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.  Hepatology. 2005;  41 1313-1321
    CrossrefPubMedGoogle Scholar
  • 78 Gholam P M, Flancbaum L, Machan J T, Charney D A, Kotler D P. Nonalcoholic fatty liver disease in severely obese subjects.  Am J Gastroenterol. 2007;  102(2) 399-408
    CrossrefPubMedGoogle Scholar
  • 79 Solga S F, Clark J M, Alkhuraishi A R et al.. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients.  Surg Obes Relat Dis. 2005;  1(1) 6-11
    CrossrefPubMedGoogle Scholar
  • 80 Kunde S S, Lazenby A J, Clements R H, Abrams G A. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.  Hepatology. 2005;  42(3) 650-656
    CrossrefPubMedGoogle Scholar
  • 81 Abrams G A, Kunde S S, Lazenby A J, Clements R H. Portal fibrosis and hepatic steatosis in morbidly obese subjects: a spectrum of nonalcoholic fatty liver disease.  Hepatology. 2004;  40(2) 475-483
    CrossrefPubMedGoogle Scholar
  • 82 Beymer C, Kowdley K V, Larson A, Edmonson P, Dellinger E P, Flum D R. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.  Arch Surg. 2003;  138(11) 1240-1244
    PubMedGoogle Scholar
  • 83 Spaulding L, Trainer T, Janiec D. Prevalence of non-alcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass.  Obes Surg. 2003;  13(3) 347-349
    CrossrefPubMedGoogle Scholar
  • 84 Ong J P, Elariny H, Collantes R et al.. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.  Obes Surg. 2005;  15(3) 310-315
    CrossrefPubMedGoogle Scholar
  • 85 Albano E, Mottaran E, Vidali M et al.. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.  Gut. 2005;  54(7) 987-993
    CrossrefPubMedGoogle Scholar
  • 86 Angelico F, Del B M, Conti R et al.. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.  J Clin Endocrinol Metab. 2005;  90(3) 1578-1582
    CrossrefPubMedGoogle Scholar
  • 87 Kelley D E, McKolanis T M, Hegazi R A, Kuller L H, Kalhan S C. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.  Am J Physiol Endocrinol Metab. 2003;  285(4) E906-E916
    PubMedGoogle Scholar
  • 88 Kotronen A, Juurinen L, Hakkarainen A et al.. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.  Diabetes Care. 2008;  31(1) 165-169
    CrossrefPubMedGoogle Scholar
  • 89 Guha I N, Parkes J, Roderick P R, Harris S, Rosenberg W M. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.  Gut. 2006;  55(11) 1650-1660
    CrossrefPubMedGoogle Scholar
  • 90 Angulo P, Keach J C, Batts K P, Lindor K D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.  Hepatology. 1999;  30(6) 1356-1362
    CrossrefPubMedGoogle Scholar
  • 91 Dixon J B, Bhathal P S, O'Brien P E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.  Gastroenterology. 2001;  121(1) 91-100
    CrossrefPubMedGoogle Scholar
  • 92 Mofrad P, Contos M J, Haque M et al.. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.  Hepatology. 2003;  37(6) 1286-1292
    CrossrefPubMedGoogle Scholar
  • 93 Sheth S G, Gordon F D, Chopra S. Nonalcoholic steatohepatitis.  Ann Intern Med. 1997;  126(2) 137-145
    PubMedGoogle Scholar
  • 94 Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P. Gender, fatty liver and GGT.  Hepatology. 2006;  44(1) 278-279
    CrossrefPubMedGoogle Scholar
  • 95 McKenzie J, Fisher B M, Jaap A J, Stanley A, Paterson K, Sattar N. Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial.  Clin Endocrinol (Oxf). 2006;  65(1) 40-44
    CrossrefPubMedGoogle Scholar
  • 96 Enzi G, Gasparo M, Biondetti P R, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography.  Am J Clin Nutr. 1986;  44(6) 739-746
    PubMedGoogle Scholar
  • 97 Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres J P. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness.  Am J Clin Nutr. 1993;  58(4) 463-467
    CrossrefPubMedGoogle Scholar
  • 98 Petersen K F, Befroy D, Dufour S et al.. Mitochondrial dysfunction in the elderly: possible role in insulin resistance.  Science. 2003;  300(5622) 1140-1142
    CrossrefPubMedGoogle Scholar
  • 99 Fink R I, Kolterman O G, Griffin J, Olefsky J M. Mechanisms of insulin resistance in aging.  J Clin Invest. 1983;  71(6) 1523-1535
    CrossrefPubMedGoogle Scholar
  • 100 Caldwell S H, Harris D M, Patrie J T, Hespenheide E E. Is NASH underdiagnosed among African Americans?.  Am J Gastroenterol. 2002;  97(6) 1496-1500
    CrossrefPubMedGoogle Scholar
  • 101 Caldwell S H, Ikura Y, Iezzoni J C, Liu Z. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?.  J Gastroenterol Hepatol. 2007;  22(suppl 1) S11-S19
    CrossrefPubMedGoogle Scholar
  • 102 Amarapurkar D N, Hashimoto E, Lesmana L A, Sollano J D, Chen P J, Goh K L. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?.  J Gastroenterol Hepatol. 2007;  22(6) 788-793
    CrossrefPubMedGoogle Scholar
  • 103 Petersen K F, Dufour S, Feng J et al.. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.  Proc Natl Acad Sci U S A. 2006;  103(48) 18273-18277
    CrossrefPubMedGoogle Scholar
  • 104 Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome.  Arterioscler Thromb Vasc Biol. 2008;  28(1) 27-38
    CrossrefPubMedGoogle Scholar
  • 105 Ikai E, Ishizaki M, Suzuki Y, Ishida M, Noborizaka Y, Yamada Y. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people.  J Hum Hypertens. 1995;  9(2) 101-105
    PubMedGoogle Scholar
  • 106 Kang H, Greenson J K, Omo J T et al.. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.  Am J Gastroenterol. 2006;  101(10) 2247-2253
    CrossrefPubMedGoogle Scholar
  • 107 Marchesini G, Bugianesi E, Forlani G et al.. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.  Hepatology. 2003;  37(4) 917-923
    CrossrefPubMedGoogle Scholar
  • 108 Jakobsen M U, Berentzen T, Sorensen T I, Overvad K. Abdominal obesity and fatty liver.  Epidemiol Rev. 2007;  29 77-87
    CrossrefPubMedGoogle Scholar
  • 109 Bellentani S, Bedogni G, Miglioli L, Tiribelli C. The epidemiology of fatty liver.  Eur J Gastroenterol Hepatol. 2004;  16(11) 1087-1093
    CrossrefPubMedGoogle Scholar
  • 110 Diehl A M. Hepatic complications of obesity.  Gastroenterol Clin North Am. 2005;  34(1) 45-61
    CrossrefPubMedGoogle Scholar
  • 111 Bellentani S, Saccoccio G, Masutti F et al.. Prevalence of and risk factors for hepatic steatosis in Northern Italy.  Ann Intern Med. 2000;  132(2) 112-117
    PubMedGoogle Scholar
  • 112 Nair S, Mason A, Eason J, Loss G, Perrillo R P. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?.  Hepatology. 2002;  36(1) 150-155
    CrossrefPubMedGoogle Scholar
  • 113 Norman D, Bardwell W A, Arosemena F et al.. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea.  Sleep. 2008;  31(1) 121-126
    PubMedGoogle Scholar
  • 114 Kallwitz E R, Herdegen J, Madura J, Jakate S, Cotler S J. Liver enzymes and histology in obese patients with obstructive sleep apnea.  J Clin Gastroenterol. 2007;  41(10) 918-921
    CrossrefPubMedGoogle Scholar
  • 115 Acarturk G, Unlu M, Yuksel S, Albayrak R, Koken T, Peker Y. Obstructive sleep apnoea, glucose tolerance and liver steatosis in obese women.  J Int Med Res. 2007;  35(4) 458-466
    PubMedGoogle Scholar
  • 116 Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk G Y. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.  Dig Dis Sci. 2005;  50(12) 2338-2343
    CrossrefPubMedGoogle Scholar
  • 117 Savransky V, Nanayakkara A, Vivero A et al.. Chronic intermittent hypoxia predisposes to liver injury.  Hepatology. 2007;  45(4) 1007-1013
    CrossrefPubMedGoogle Scholar
  • 118 Zamora-Valdes D, Mendez-Sanchez N. Experimental evidence of obstructive sleep apnea syndrome as a second hit accomplice in nonalcoholic steatohepatitis pathogenesis.  Ann Hepatol. 2007;  6(4) 281-283
    PubMedGoogle Scholar
  • 119 Tanne F, Gagnadoux F, Chazouilleres O et al.. Chronic liver injury during obstructive sleep apnea.  Hepatology. 2005;  41(6) 1290-1296
    CrossrefPubMedGoogle Scholar
  • 120 Abdelmalek M F, Liu C, Shuster J, Nelson D R, Asal N R. Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease.  Clin Gastroenterol Hepatol. 2006;  4(9) 1162-1169
    CrossrefPubMedGoogle Scholar
  • 121 Willner I R, Waters B, Patil S R, Reuben A, Morelli J, Riely C A. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.  Am J Gastroenterol. 2001;  96(10) 2957-2961
    CrossrefPubMedGoogle Scholar
  • 122 Browning J D, Kumar K S, Saboorian M H, Thiele D L. Ethnic differences in the prevalence of cryptogenic cirrhosis.  Am J Gastroenterol. 2004;  99(2) 292-298
    CrossrefPubMedGoogle Scholar
  • 123 Struben V M, Hespenheide E E, Caldwell S H. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds.  Am J Med. 2000;  108(1) 9-13
    PubMedGoogle Scholar
  • 124 Wilfred de Alwis N M, Day C P. Genetics of alcoholic liver disease and nonalcoholic fatty liver disease.  Semin Liver Dis. 2007;  27(1) 44-54
    Article in Thieme ConnectPubMedGoogle Scholar
  • 125 Day C P. The potential role of genes in nonalcoholic fatty liver disease.  Clin Liver Dis. 2004;  8(3) 673-691
    CrossrefPubMedGoogle Scholar
  • 126 Cave M, Deaciuc I, Mendez C et al.. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.  J Nutr Biochem. 2007;  18(3) 184-195
    PubMedGoogle Scholar
  • 127 Jenkins D J, Josse A R, Labelle R, Marchie A, Augustin L S, Kendall C W. Nonalcoholic fatty liver, nonalcoholic steatohepatitis, ectopic fat, and the glycemic index.  Am J Clin Nutr. 2006;  84(1) 3-4
    PubMedGoogle Scholar
  • 128 Solga S, Alkhuraishe A R, Clark J M et al.. Dietary composition and nonalcoholic fatty liver disease.  Dig Dis Sci. 2004;  49(10) 1578-1583
    CrossrefPubMedGoogle Scholar
  • 129 Toshimitsu K, Matsuura B, Ohkubo I et al.. Dietary habits and nutrient intake in non-alcoholic steatohepatitis.  Nutrition. 2007;  23(1) 46-52
    CrossrefPubMedGoogle Scholar
  • 130 Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R et al.. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study.  J Hepatol. 2007;  47(5) 711-717
    CrossrefPubMedGoogle Scholar
  • 131 Solga S F, Diehl A M. Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics.  J Hepatol. 2003;  38(5) 681-687
    PubMedGoogle Scholar
  • 132 Solga S F, Diehl A M. Gut flora-based therapy in liver disease? The liver cares about the gut.  Hepatology. 2004;  39(5) 1197-1200
    CrossrefPubMedGoogle Scholar
  • 133 Wigg A J, Roberts-Thomson I C, Dymock R B, McCarthy P J, Grose R H, Cummins A G. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis.  Gut. 2001;  48(2) 206-211
    CrossrefPubMedGoogle Scholar
  • 134 Ekstedt M, Franzen L E, Mathiesen U L et al.. Long-term follow-up of patients with NAFLD and elevated liver enzymes.  Hepatology. 2006;  44(4) 865-873
    CrossrefPubMedGoogle Scholar
  • 135 Hashimoto E, Yatsuji S, Kaneda H et al.. The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease.  Hepatol Res. 2005;  33(2) 72-76
    PubMedGoogle Scholar
  • 136 Hui J M, Kench J G, Chitturi S et al.. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.  Hepatology. 2003;  38(2) 420-427
    PubMedGoogle Scholar
  • 137 Sanyal A J, Banas C, Sargeant C et al.. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.  Hepatology. 2006;  43(4) 682-689
    CrossrefPubMedGoogle Scholar
  • 138 Sanyal A J. AGA technical review on nonalcoholic fatty liver disease.  Gastroenterology. 2002;  123(5) 1705-1725
    CrossrefPubMedGoogle Scholar
  • 139 Villanova N, Moscatiello S, Ramilli S et al.. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.  Hepatology. 2005;  42(2) 473-480
    CrossrefPubMedGoogle Scholar
  • 140 Volzke H, Robinson D M, Kleine V et al.. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.  World J Gastroenterol. 2005;  11(12) 1848-1853
    CrossrefPubMedGoogle Scholar
  • 141 Stranges S, Trevisan M, Dorn J M, Dmochowski J, Donahue R P. Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study.  Hypertension. 2005;  46(5) 1186-1193
    CrossrefPubMedGoogle Scholar
  • 142 Hanley A J, Williams K, Festa A et al.. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.  Diabetes. 2004;  53(10) 2623-2632
    PubMedGoogle Scholar
  • 143 Hanley A J, Williams K, Festa A, Wagenknecht L E, D'Agostino Jr R B, Haffner S M. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.  Diabetes. 2005;  54(11) 3140-3147
    CrossrefPubMedGoogle Scholar

Mariana Lazo M.D. M.Sc. 

Welch Center for Prevention, Epidemiology, and Clinical Research

2024 E. Monument Street, Suite 2-600, Baltimore, MD 21205-2223

Email: mlazo@jhsph.edu